The MTHFD1 gene is located on chromosome 14q23.3 and is composed of 28 exons that generate two alternatively spliced mRNAs that encode distinct protein isoforms
However, the appearance can be improved through weight loss or effective treatment for any associated endocrinopathy or malignancy
Thus, in perfect agreement with the recent ADA-EASD consensus report [6], we also encourage the adoption of GLP-1RA plus SGLT2i combination therapy in T2DM patients with established ASCVD (coronary artery disease, cerebrovascular disease, or peripheral arterial disease) or multiple risk factors for ASCVD (i.e., age 55 years, obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria) whose HbA1c remains suboptimal despite initial treatment with only one of these agents
This reduces their strength and bioavailability before they ever reach your brain
Now for the math